DJ

Dwaipayan Jha

Active Director Director DIN 09158434
DIN 09158434 First appointment Apr 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Dwaipayan Jha

Data last updated:

Dwaipayan Jha is a Director at Indo Asia International Hospital Private Limited (since 2021). The company operates in Healthcare.

DIN 09158434
Primary Designation Director
Industry Healthcare
First Appointment 27 Apr 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Apr 20212021Active

Directorship timeline

Open interactive timeline →
Indo Asia International Hospital Private Limited
Premium access

Shareholding and investment profile for Dwaipayan Jha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dwaipayan Jha

Dwaipayan Jha currently holds 1 directorship: Indo Asia International Hospital Private Limited (Director, since 27 Apr 2021).

Dwaipayan Jha was first appointed on 27 Apr 2021 as Director at Indo Asia International Hospital Private Limited.

The current boards of Dwaipayan Jha's companies include Mohammed Sharique Sayeed (Indo Asia International Hospital Private Limited), Rina Barman (Indo Asia International Hospital Private Limited), Sumantra Ray (Indo Asia International Hospital Private Limited), Sunilbaran Daschakraborty (Indo Asia International Hospital Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available